Tyra Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +487.5% | +197.9% | +111.4% | +20.6% | +45.4% | +5.2% | |
| – | – | +557.6% | +266.7% | +27.7% | +68.6% | +22.8% | |
| – | -51.2% | +533.8% | +266.5% | – | – | – | |
| – | +111.9% | -145.0% | – | – | -111.5% | – | |
| – | +1,460.0% | +111.9% | -15.4% | +37.7% | -13.8% | -78.8% | |
| – | +1,460.0% | +106.7% | -13.3% | +25,768.5% | -32.0% | – | |
| – | – | – | – | – | – | -100.0% | |
| – | +112.5% | +47.1% | -100.0% | – | – | – | |
| – | +14,826.1% | +1,228.6% | -99.8% | +143.2% | +13,051.4% | -96.0% | |
| – | – | +1,768.3% | -117.8% | – | – | -142.9% | |
| – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.